EC HEALTHCARE (02138) Reports Interim Results: Net Loss Attributable to Equity Shareholders of HK$10.312 Million, Shifting from Profit to Loss YoY

Stock News11-28

EC HEALTHCARE (02138) announced its interim results for the six months ended September 30, 2025. The company reported total revenue of approximately HK$1.931 billion, representing a year-on-year decrease of 6.4%. Net loss attributable to equity shareholders amounted to HK$10.312 million, compared to a profit in the same period last year. The loss per share was HK$0.009.

The decline in profitability was primarily attributed to reduced revenue and sales volume, which lowered operating leverage across major business segments. Additionally, a shift in service mix toward lower-margin categories and the absence of income from divested medical assets—which contributed to profits in the prior-year period—further impacted the group's earnings.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment